These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34611554)

  • 1. Circulatory 25(OH)D and 1,25(OH)
    Ogura H; Hatip-Al-Khatib I; Suenaga M; Hatip FB; Mishima T; Fujioka S; Ouma S; Matsunaga Y; Tsuboi Y
    eNeurologicalSci; 2021 Dec; 25():100369. PubMed ID: 34611554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease.
    Barichella M; Cereda E; Iorio L; Pinelli G; Ferri V; Cassani E; Bolliri C; Caronni S; Pusani C; Schiaffino MG; Giana A; Quacci E; Esposito C; Monti Guarnieri F; Colombo A; Sorbo FD; Cilia R; Sacilotto G; Riboldazzi G; Zecchinelli AL; Pezzoli G
    Nutr Neurosci; 2022 Jun; 25(6):1128-1136. PubMed ID: 33151126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatosensory temporal discrimination threshold may help to differentiate patients with multiple system atrophy from patients with Parkinson's disease.
    Rocchi L; Conte A; Nardella A; Li Voti P; Di Biasio F; Leodori G; Fabbrini G; Berardelli A
    Eur J Neurol; 2013 Apr; 20(4):714-9. PubMed ID: 23278905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
    Lipp A; Sandroni P; Ahlskog JE; Fealey RD; Kimpinski K; Iodice V; Gehrking TL; Weigand SD; Sletten DM; Gehrking JA; Nickander KK; Singer W; Maraganore DM; Gilman S; Wenning GK; Shults CW; Low PA
    Arch Neurol; 2009 Jun; 66(6):742-50. PubMed ID: 19506134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders.
    Kakimoto A; Ogura H; Suenaga M; Mishima T; Fujioka S; Ouma S; Matsunaga Y; Tsuboi Y
    Clin Park Relat Disord; 2022; 7():100162. PubMed ID: 36072127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in multiple system atrophy.
    Schrag A; Geser F; Stampfer-Kountchev M; Seppi K; Sawires M; Köllensperger M; Scherfler C; Quinn N; Pellecchia MT; Barone P; Del Sorbo F; Albanese A; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Nilsson CF; Widner H; Lindvall O; Giladi N; Gurevich T; Daniels C; Deuschl G; Coelho M; Sampaio C; Abele M; Klockgether T; Schimke N; Eggert KM; Oertel W; Djaldetti R; Colosimo C; Meco G; Poewe W; Wenning GK;
    Mov Disord; 2006 Jun; 21(6):809-15. PubMed ID: 16502399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gait parameters between drug-naïve patients diagnosed with multiple system atrophy with predominant parkinsonism and Parkinson's disease.
    Na BS; Ha J; Park JH; Ahn JH; Kim M; Kim JS; Kim HT; Cho JW; Youn J
    Parkinsonism Relat Disord; 2019 Mar; 60():87-91. PubMed ID: 30266299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.
    Chen D; Wei X; Zou J; Wang R; Liu X; Xu X; Lu J; Wang Z; Tang B; Wang B; Jin K; Wang Q
    Front Cell Neurosci; 2015; 9():247. PubMed ID: 26217177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor assessment of patients with multiple system atrophy: underuse of the Unified Multiple System Atrophy Rating Scale (UMSARS).
    Ferreirós A; Castillo-Torres SA; Merello M
    Clin Auton Res; 2023 Apr; 33(2):143-148. PubMed ID: 36971870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson's disease and multiple system atrophy--comparison with normal elderly.
    Wang Y; Shao WB; Gao L; Lu J; Gu H; Sun LH; Tan Y; Zhang YD
    PLoS One; 2014; 9(12):e116123. PubMed ID: 25546308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study.
    Markopoulou K; Aasly J; Chung SJ; Dardiotis E; Wirdefeldt K; Premkumar AP; Schoneburg B; Kartha N; Wilk G; Wei J; Simon KC; Tideman S; Epshteyn A; Hadsell B; Garduno L; Pham A; Frigerio R; Maraganore D
    Front Neurol; 2020; 11():548. PubMed ID: 32733352
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey.
    You HY; Wu L; Yang HT; Yang C; Ding XL
    Pain Res Manag; 2019; 2019():3150306. PubMed ID: 30805069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson's Disease: Implications for Clinical Practice.
    Yang L; Chen Z; Li B; Wang M; Yu L; Wan Y; Gan J; Zhang Y; Liu Z; Wang X
    Front Aging Neurosci; 2017; 9():355. PubMed ID: 29163137
    [No Abstract]   [Full Text] [Related]  

  • 19. A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes.
    Li Q; Li Z; Han X; Shen X; Wang F; Bai L; Li Z; Zhang R; Wang Y; Zhu X
    Front Neurosci; 2022; 16():805953. PubMed ID: 35250451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy.
    Guo Y; Zhuang XD; Xian WB; Wu LL; Huang ZN; Hu X; Zhang XS; Chen L; Liao XX
    CNS Neurosci Ther; 2017 Aug; 23(8):657-666. PubMed ID: 28628270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.